Effects on PaCO2 Levels of Two Different Nasal Cannula in COPD Patients

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

October 30, 2023

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

AIRVO 2, with conventional symmetric nasal cannula

"The patients will be asked to breathe with HFNC at flow of 40 L/min with the standard cannula~The size of nasal cannula will be selected to occlude patient's nostril of about 2/3.~Temperature will be set according to the patient's tolerance starting from 31°C, up to 37°C, while FiO2 is adjusted to maintain SpO2 between 88 and 92%."

DEVICE

AIRVO 2, the new asymmetric nasal cannula

"The patients will be asked to breathe with HFNC at flow of 40 L/min with the new asymmetric nasal cannula~The size of nasal cannula will be selected to occlude patient's nostril of about 2/3.~Temperature will be set according to the patient's tolerance starting from 31°C, up to 37°C, while FiO2 is adjusted to maintain SpO2 between 88 and 92%."

Trial Locations (1)

40138

IRCCS Policlinico di Sant'Orsola, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER